Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000559524 | SCV000651658 | likely benign | Charcot-Marie-Tooth disease axonal type 2O | 2025-01-07 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172875 | SCV001335948 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001545611 | SCV001764978 | likely benign | not provided | 2019-08-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367930 | SCV002657939 | benign | Inborn genetic diseases | 2019-03-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004745472 | SCV005351729 | likely benign | DYNC1H1-related disorder | 2024-09-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |